Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 23.38
+0.04 (0.17%)
Sep 9, 2026, 12:38 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.29 billion as of September 8, 2026. Its market cap has decreased by -50.21% in one year.
Market Cap
1.29B
Enterprise Value
1.70B
Revenue
2.80B
Ranking
n/a
PE Ratio
52.20
Stock Price
23.38
ChartMarket Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.29B, an increase of 3,005.22%. That is a compound annual growth rate of 37.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 1.29B | -13.14% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 8.30B |
| Amanta Healthcare | 7.84B |
| Bafna Pharmaceuticals | 7.28B |
| Valiant Laboratories | 6.20B |
| Nectar Lifesciences | 2.36B |
| Brooks Laboratories | 1.86B |
| Par Drugs and Chemicals | 1.74B |
| Alpa Laboratories | 1.33B |